Hyundai Motor Executive Vice Chairman Chung Euisun and Samsung Group leader Lee Jae-yong discussed further cooperation in electric vehicles (EVs), as US-based Tesla pursues more EV sales in South Korea.
The meeting was held at Hyundai's Namyang R&D Center in Gyeonggi Province.
With Samsung's expertise in chips, displays, and EV battery cells complementing Hyundai's fuel-cell and EV capabilities, industry analysts expect the Samsung-Hyundai partnership to provide strong competition to Tesla.
The two business leaders also reviewed self-driving technology and urban air mobility (UAM) sectors.
Chung and Lee had earlier discussed business at the Cheonan plant of Samsung SDI.
Samsung has indicated that the EV battery business will be one of its next growth engines.
Hyundai Motor Group has made partnerships with EV battery makers as a top priority to establish a stable supply chain before mass-producing EVs. It aims to offer 23 EV models and sell a million EVs by 2025.
Chung has already met with the heads of local battery makers, including SK Group Chairman Chey Tae-won and LG Group Chairman Koo Kwang-mo.


SEC Sues Former Tricolor Executives Over $1.9 Billion Investor Fraud Scheme
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Lockheed Martin Secures $153.5 Million in U.S. Defense Contracts
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
Standard Chartered Expands Hedge Fund Access for Wealth Clients
Anthropic Revenue Run Rate Hits $65 Billion as IPO Plans Accelerate
Coty Revenue Beats Estimates as Beauty Demand Holds Firm
CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
REPAY Stock Rises After Visa Platform Connect Collaboration
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
OpenAI Tightens AI Safety Monitoring After Security Incidents
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push 



